ArticleLeukemia2020

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.

Bader Alanazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.